Orforglipron
ACHIEVE-4
Eli Lilly · Phase 3 · Completed · Enrollment 2749
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Orforglipron | n/r | n/r | n/r | n/r | n/r |
| Insulin Glargine | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.